保龄宝(002286) - 2018 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2018 was ¥386,847,215.18, representing a 3.07% increase compared to ¥375,311,325.81 in the same period last year[8] - The net profit attributable to shareholders was ¥14,273,392.27, a 1.21% increase from ¥14,103,253.91 year-on-year[8] - The net profit after deducting non-recurring gains and losses decreased by 17.61% to ¥9,924,466.48 from ¥12,045,424.97 in the previous year[8] - The net profit attributable to shareholders for the first half of 2018 is expected to be between RMB 36.31 million and RMB 54.46 million, representing a growth of 0.00% to 50.00% compared to the same period in 2017[23] Cash Flow and Assets - The net cash flow from operating activities was ¥33,978,190.86, a significant improvement from a negative cash flow of ¥7,273,424.30 in the same period last year[8] - Total assets at the end of the reporting period were ¥2,290,364,925.47, an increase of 8.71% from ¥2,106,919,776.89 at the end of the previous year[8] - The net assets attributable to shareholders increased by 0.74% to ¥1,534,117,810.92 from ¥1,522,850,018.45 at the end of the previous year[8] - The company’s cash and cash equivalents increased by 41.97% compared to the beginning of the year, mainly due to increased bank loans and the maturity of bank wealth management products[20] - The company’s inventory increased by 43.99% compared to the beginning of the year, primarily due to an increase in raw material storage[20] - The company’s operating cash flow net amount increased by RMB 41.25 million year-on-year, primarily due to an increase in cash received from sales[20] - The company’s short-term financial investments increased by 13,600.88% compared to the beginning of the year[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,268[12] - The largest shareholder, Liu Zongli, held 15.05% of the shares, totaling 55,585,497 shares[12] Government Support and Investments - The company received government subsidies amounting to ¥4,960,889.43 during the reporting period[9] - The company plans to establish an industrial investment fund with a total scale of RMB 1.056 billion, with a commitment of RMB 500 million from the company[18] - The company signed an agreement to acquire 11.37% of China Regenerative Medicine International Limited for HKD 360 million[19] Financial Expenses - The company’s financial expenses increased by 337.63% year-on-year, mainly due to exchange rate fluctuations and increased bank interest expenses[20] Other Information - The weighted average return on net assets was 0.94%, slightly up from 0.93% in the previous year[8] - The company has no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[22]